Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

$967K USD

Funder	National Institutes of Health
Recipient Organization	Not specified
Country	USA
Start Date	Nov 20, 2024
End Date	Sep 08, 2030
Duration	2,118 days
Number of Grantees	1
Data Source	Grants.gov
Grant ID	`3123ee82-9741-44ce-a5b9-08cac5bb1981`

Grant Description

This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine).

This NOFO will also support research on the persistent and/or delayed pathophysiological effects after acute exposure to such agents.